pLKO.puro_shGLS Citations (1)
Originally described in: GLS2 is protumorigenic in breast cancers.Dias MM, Adamoski D, Dos Reis LM, Ascencao CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20. PubMed Journal
Articles Citing pLKO.puro_shGLS
| Articles |
|---|
| Inhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cells. Kim J, Brunetti B, Kumar A, Mangla A, Honda K, Yoshida A. Cell Death Dis. 2024 Dec 18;15(12):902. doi: 10.1038/s41419-024-07284-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.